Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Campus
Campus

Prurigo Nodularis

Get a global overview and learn all about the changing world of Prurigo Nodularis.

Science in Prurigo Nodularis

Get a 360º view and stay updated on Prurigo Nodularis with content selected for you

PN Expert Interview Series with Dr. Shawn Kwatra

PN Expert Interview Series with Dr. Shawn Kwatra

Learn More
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

Learn More
There is Significant Unmet Need in the Management of PN¹

Rethink

Learn More
Mechanism of Prurigo Nodularis Disease

Mechanism of Prurigo Nodularis Disease

In this comprehensive exploration, we delve into the intricate pathophysiology of Prurigo Nodularis (PN), highlighting the pivotal roles of neuronal sensitization, inflammation, and pruritus. This challenging dermatological condition is characterized by dermatological condition histopathologic alterations, including enhanced hypervascularization, epidermal hyperkeratosis, and dermal fibrosis. Explore the connection between PN and the proinflammatory Th2 cytokine IL-13, shedding light on its binding to IL-4R across various skin components.

Learn More
Prurigo Nodularis is a Distinct, Chronic, Neural and Immune- Mediated skin Disease characterized by Intense Itch and Nodular Lesions¹

Recognize

Learn More
Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology¹

Discover

Exact pathophysiology of PN is currently not understood. Based on the evolving literature, type 2 inflammation may play a role in PN.

Learn More

Events

Stay up to date and register for the latest events and view webinar recordings.

Type 2 Inflammation and Prurigo Nodularis

Type 2 Inflammation and Prurigo Nodularis

Learn More